Ok, So in my typical review of the CC, I thought it was

New Post Public Reply Private Reply Replies (0) Message Board
longboardsurfer90210
Ok, So in my typical review of the CC, I thought it was good. Again, review what has been going on with the company over the last two years and what they have accomplished. Are we all rich beyond our dreams? Doing pretty good I would say for those who have been around for a while. They are doing things right. Very calculated. A lot going on in many fronts. The call was detailed and did not sound as if Gerald was trying to cover anything up that was not already discussed in the past. They continue to learn from past mistakes/blunders (which aren't many) and are on a path to make AMBS a world class company. Think of the amount of directions and opportunities that exist. If any one of them comes to fruition, we will be fine. Based on how careful they are being bringing Lympro to market, I would say we are in good hands. To those who are unhappy with the direction AMBS is going, I say, "please enlighten us". What are we missing? All the people that surround this company, the research that is being done on MANF independent of AMBS, a blood test that makes economical sense for major pharma, ELTZ for Parkinsons, etc etc etc. Just sayin! The PPS is going to do what its going to do, especially down here in OTC land. Stop looking every minute and realize and remember why you invested in the first place. Heck, when I got here all we had was MANF. That was enough for me at the time. Gerald is not here to mislead investors for his own greed as some might suggest on other boards, They have a vision and are working hard to make it a reality. I have to respect that. Thats what makes me a shareholder. 2.7 million strong for over two years and I still sleep fine. Nothing has changed from the last quarter or even last quarter last year in terms of execution. The fact that R&D expense increased is a positive. I would have been worried had it gone down. Then I would be wondering what they are doing with their time. Ok, so thats my two cents for the quarterly CC. Just thought I would share my thoughts. Peace!

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Lawsuit Targets Lincoln Educational Services

Updated Category News Views 3

Legal Maneuver Against Lincoln Educational Services Here we go again—another day, another lawsuit. The recent flap with Lincoln Educational Services Corporation (NASDAQ: LINC) is as classic as any market rug pull. Stepping into the spotlight, Wolf Haldenstein Adler Freeman & Herz LLP—a courtroom icon since 1888—has announced a class action lawsuit against Lincoln....

Continue Reading
Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 5

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 3

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 9

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
First Lady Steals NYSE Show, Investors Eye Stakes

Updated Category News Views 3

Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...

Continue Reading
EZ Elephant's Ladder-Free Gutter Fix Debuts at Expo

Updated Category News Views 2

A New Leaf in Gutter Maintenance From the ground up, EZ Elephant is redefining how we tackle gutter maintenance. Picture it: never having to teeter on that wobbly ladder again just to unclog your gutters. This American-made solution, showcased at the Western Roofing Expo from September 27–29, 2026, is a game changer. Check out Booth #834 to see this marvel of innovation...

Continue Reading
GoLive Streamers: A Social Media Wild Card

Updated Category News Views 3

Stepping Boldly into the Livestreaming Arena There's a new kid in the chaotic neighborhood of social media, and it's called GoLive Streamers. Not just another aimless stroll down Content Highway, GoLive is weaving its own defining path by fostering genuine real-time interaction. Launched in April 2026, this plucky platform has quickly amassed a following of over 74,000...

Continue Reading
RunVermont Revamps City Marathon, Adds Half for 2027

Updated Category News Views 2

Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...

Continue Reading
Riverside Theatre Appoints Seasoned CFO for Growth Phase

Updated Category News Views 3

Change Is Afoot at Riverside Theatre Down in Vero Beach, amid the sun-drenched coziness of Florida’s Treasure Coast, something’s cooking that has nothing to do with sunshine: Riverside Theatre snagged itself a new Chief Financial Officer. As nonprofits go, this one’s not a backyard operation—it’s the largest independent professional theatre in the entire state....

Continue Reading
BlueCollar Backs SuiteWorld 2026 with Platinum Sponsorship

Updated Category News Views 3

BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...

Continue Reading

Top 5 Most Recently Viewed Articles

Castelion Raises $1B For Hypersonic Weapon Production

Updated Category News Views 25

A Mammoth Leap for Castelion When you pour a billion bucks into a company, you'd better believe they're up to something big. Castelion, a name not so familiar to the everyday investor but a hot ticket in defense technology, just made headlines by securing a monstrous $1 billion Series C funding. If you think hypersonic weapons belong in sci-fi flicks, think again. These...

Continue Reading
Ibotta Plans Participation in Major Investor Conferences

Updated Category News Views 66

Ibotta to Participate in Major Investor Conferences Ibotta, Inc. (NYSE: IBTA), a leading technology firm focused on digital promotions and performance marketing, has announced its participation in key investor conferences. This proactive engagement underscores the company's dedication to sharing its growth strategies and market presence with investors. Upcoming Investor...

Continue Reading
Transforming Air Medical Services with Liquid Oxygen Technology

Updated Category News Views 175

New Milestone for Life Flight Network and Spectrum Aeromed Life Flight Network, a leading air medical transport service, is proud to collaborate with Spectrum Aeromed in rolling out an innovative liquid oxygen (LOX) system in its newly acquired Pilatus PC-12 aircraft. This marks a significant leap in the capabilities of air medical transport, ensuring that patients...

Continue Reading
Unicycive Therapeutics Faces Investigation Over Stock Concerns

Updated Category News Views 223

Unicycive Therapeutics Under Investigation for Securities Fraud In recent developments, Pomerantz LLP has initiated an investigation into the possible fraudulent activities involving Unicycive Therapeutics, Inc. (NASDAQ: UNCY). The inquiry focuses on whether the company and its executives may have violated securities laws, an issue that could have implications for many...

Continue Reading
ResiHome Partners to Enhance Property Management Services

Updated Category News Views 561

ResiHome Expands Third-Party Property Management Services ResiHome, a frontrunner in managing single-family rentals (SFR) and build-to-rent (BTR) properties, has taken a significant step in expanding its third-party services. In a new partnership, ResiHome will assume management of two BTR communities, Copperleaf Townhomes and The Townes at Clairbrook. This strategic...

Continue Reading